Paul McCartney, de 83 anos, anunciou recentemente o lançamento de um novo álbum para o dia 29 de maio, o primeiro desde dezembro de 2020, junto da divulgação de um single carregado de nostalgia.

“Love Is the Monster” (“El amor es el monstro”), a tropical dystopia thriller from Neto Villalobos whose “All About the ...

The U.S. Food and Drug Administration (FDA) has issued a warning to Novo Nordisk over its alleged failure to report adverse side effects, including death, in patients who took its GLP-1 medications, ...

The Food and Drug Administration issued a warning letter to Novo Nordisk — the maker of Ozempic and Wegovy — for failing to report potential side effects in patients who took its blockbuster ...

Novo Nordisk is investing $506 million to expand manufacturing capabilities in Ireland. The move will strengthen its ability to meet both current and future demand for its oral medicines, said Novo ...

The prices of popular weight loss drugs Ozempic and Wegovy are to fall dramatically from next year, Danish drugmaker Novo Nordisk said Tuesday. The list price of Wegovy will be cut in half on January ...

Novo Nordisk announced Tuesday it will be slashing the list price of its blockbuster GLP-1 medications, Ozempic, Wegovy and Rybelsus, by up to 50 percent beginning next year. Starting on Jan. 1, 2027, ...

Novo Nordisk and its Chinese partner have reported up to 19.7% weight loss in patients who took their triple agonist for 24 weeks, illuminating a potential path forward for the Danish drugmaker as it ...

The weight-loss drugs that kicked off America's GLP-1 craze are about to get a lot less expensive, though only certain customers will notice the savings. Novo Nordisk said it will slash list prices of ...

CHARLESTON, S.C. (WCSC) — Local nonprofit AMOR Healing Kitchen is marking its eighth anniversary with a public festival Saturday, as the organization continues delivering free meals to Lowcountry ...

Novo Nordisk competes with Eli Lilly in the GLP-1 space. Novo Nordisk's recently launched GLP-1 pill could help reset the game. Adding to the company's woes is Novo Nordisk's weak guidance for 2026.

Novo Nordisk A/S aims to start selling its weight-loss blockbuster Wegovy in vials, its latest move to win over customers it’s lost to rival Eli Lilly & Co. Currently Novo sells the drug in plastic ...